HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

LVMH v. Gucci

This article was originally published in The Rose Sheet

Executive Summary

LVMH filing appeal in Dutch Supreme Court following the rejection of the company's case against Gucci by Amsterdam court of appeals May 27 ("The Rose Sheet" May 31, In Brief). The suit argues the court's decision to not approve an investigation into Gucci's acquisition of Pinault-Printemps-Reddoute was made in "error." LVMH also is seeking nullification of a number of management decisions by Gucci in Amsterdam district court, including an option for PPR to nominate four of nine Gucci supervisory board members; the creation of a five-member strategic and financial committee with three PPR members; and an option for PPR to acquire 10% of Gucci's fully diluted shares. Gucci deemed the appeal "inappropriate and vexatious"

Latest Headlines
See All
UsernamePublicRestriction

Register

RS006784

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel